Cat.#: ACPP-1366
| Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1109 | Recombinant Human Somatostatin Receptor 2 Protein (Fc Tag) (AC1109) | 50 µg | inquiry |
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
| ACPP-1732 | Human CHRNA6 Protein (AC1732) | 5 µg | inquiry |
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
| ACPP-1489 | Human PSPN Protein (AC1489) | 5 µg | inquiry |
| ACPP-1794 | Human BAIAP2 Protein (AC1794) | 5 µg | inquiry |
| ACPP-1278 | EAAT1 Blocking Peptide (AC1278) | 250 µg | inquiry |
| ACPP-1841 | Human DDAH1 Protein (AC1841) | 5 µg | inquiry |
| ACPP-1380 | Human LECT2 Protein (AC1380) | 2 µg | inquiry |
| ACPP-1137 | Recombinant HuD Antigen (AC1137) | 100 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.